Journal Article Summary

The article investigates the effects of synthetic progestins on the growth and spread of human breast cancer cells in a mouse model. This research is significant because it addresses concerns about the potential risks associated with hormone therapy (HT) and oral contraceptives that contain progestins, particularly regarding their role in breast cancer progression. Previous studies have suggested that progestins may contribute to the development of breast cancer, making it crucial to understand their biological effects in a controlled setting.

In this study, researchers used nude mice implanted with BT-474 breast cancer cells to assess how different progestins—medroxyprogesterone acetate (MPA), norgestrel (N-EL), and norethindrone (N-ONE)—influence tumor growth and metastasis. The mice were treated with these progestins either simultaneously with estrogen or sequentially after tumor cell injection. The findings revealed that all progestins stimulated tumor growth and increased vascularization, as indicated by higher levels of vascular endothelial growth factor (VEGF). Additionally, norgestrel was found to significantly enhance the spread of cancer cells to lymph nodes, suggesting a potential increase in metastasis.

However, the study has limitations, including its reliance on a mouse model, which may not fully replicate human responses to progestins. Patients should be aware of these findings and discuss with their healthcare providers the risks associated with progestin-containing therapies, especially if they have a family history of breast cancer or other risk factors. Understanding the implications of this research can help patients make informed decisions about their treatment options and the potential need for alternative therapies that do not promote tumor growth.

Medication Safety Note

This journal article summary is provided for educational purposes only and is not medical advice. Always consult a licensed healthcare professional before starting, stopping, or changing any medication.

Article Cited

  1. Liang Yayun, Benakanakere Indira, Besch-Williford Cynthia, Hyder Ryyan S, Ellersieck Mark R., Hyder Salman M. Synthetic progestins induce growth and metastasis of BT-474 human breast cancer xenografts in nude mice. Menopause (New York, N.Y.) 2010. DOI: 10.1097/gme.0b013e3181d3dd0c. PMID: 20461021. PMCID: PMC2923240.

Featured Pill Pals Product

Pill Pals® is THE Express Pharmacy. Our Nationwide Pharmacy Network was created with the mission of helping you make SENSE of your meds™. As a Pharmacy Benefits Management organization, Pill Pals® gives patients the best cash prices on all meds. Pill Pals® is part of The Health Pals® Company (Health Pals®, Med Pals®, Skin Pals® etc), a vertically integrated Healthcare System that provides cost effective Medical and Pharmacy services to Employers, Patients, and more. For more information, please email [email protected]